stockrowIntuitive Surgical, Inc.
ISRG Healthcare Medical Instruments & Supplies
Intuitive Surgical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $10.1 billion, up 20.5% from fiscal 2024.
- Revenue
- +21.7%
- EPS
- −24.2%
- Free cash flow
- +51.0%
Quarter to September 2026, against a year earlier
Follow ISRG
Alert me
Intuitive Surgical, Inc. (ISRG) Return on equity
Intuitive Surgical, Inc.'s return on equity over the twelve months to 30 September 2026 was 17.8%, up 1.3 percentage points from fiscal 2025 (16.6%). Over the past ten years it has ranged from 11.5% (fiscal 2022) to 19.7% (fiscal 2018); the current reading is higher than 82% of that period. That is above the Medical Instruments & Supplies industry median of 0.00% and above the Healthcare sector median of −26.3%.
Return on equity, annual
Embed this chart
Annual newest first
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2025 | 16.6% | 1.05 |
| FY2024 | 15.5% | 0.85 |
| FY2023 | 14.7% | 3.20 |
| FY2022 | 11.5% | (4.23) |
| FY2021 | 15.7% | 3.94 |
| FY2020 | 11.8% | (6.66) |
| FY2019 | 18.4% | (1.25) |
| FY2018 | 19.7% | 6.96 |
| FY2017 | 12.7% | (1.91) |
| FY2016 | 14.6% | (0.68) |
Against its own ten years
Return on equity against peers
| Company | Return on equity |
|---|---|
| RMD ResMed Inc. compare | 26.4% |
| WST West Pharmaceutical Services, Inc. compare | 21.2% |
| ISRG Intuitive Surgical, Inc. | 17.8% |
| COO The Cooper Companies, Inc. compare | 6.84% |
| BDX Becton, Dickinson and Company compare | 3.77% |
| SOLV Solventum Corporation compare | 3.19% |
| MDLN Medline Inc. compare | 3.18% |
| ALC Alcon compare | 2.94% |
| BAX Baxter International Inc. compare | −10.6% |
| Medical Instruments & Supplies industry median | 0.00% |
| Healthcare sector median | −26.3% |
| Market median | 0.51% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on ISRG
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement